HK1057705A1 - Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix - Google Patents
Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrixInfo
- Publication number
- HK1057705A1 HK1057705A1 HK04100051.2A HK04100051A HK1057705A1 HK 1057705 A1 HK1057705 A1 HK 1057705A1 HK 04100051 A HK04100051 A HK 04100051A HK 1057705 A1 HK1057705 A1 HK 1057705A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- polymer matrix
- deposited onto
- sparingly soluble
- biological environment
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 239000002245 particle Substances 0.000 title abstract 5
- 239000011159 matrix material Substances 0.000 title abstract 3
- 229920000642 polymer Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 230000008021 deposition Effects 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19570000P | 2000-04-07 | 2000-04-07 | |
US09/827,100 US6998137B2 (en) | 2000-04-07 | 2001-04-05 | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
PCT/US2001/011217 WO2001076558A1 (en) | 2000-04-07 | 2001-04-06 | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1057705A1 true HK1057705A1 (en) | 2004-04-16 |
Family
ID=26891244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04100051.2A HK1057705A1 (en) | 2000-04-07 | 2004-01-19 | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
Country Status (19)
Country | Link |
---|---|
US (1) | US6998137B2 (ko) |
EP (1) | EP1267838B1 (ko) |
JP (2) | JP4731088B2 (ko) |
KR (1) | KR100923817B1 (ko) |
CN (1) | CN100518814C (ko) |
AT (1) | ATE526947T1 (ko) |
AU (1) | AU2001251389A1 (ko) |
BR (1) | BRPI0110319B1 (ko) |
CA (1) | CA2405030C (ko) |
CY (1) | CY1112294T1 (ko) |
DK (1) | DK1267838T3 (ko) |
ES (1) | ES2374224T3 (ko) |
HK (1) | HK1057705A1 (ko) |
IL (2) | IL152131A0 (ko) |
MX (1) | MXPA02009790A (ko) |
NZ (1) | NZ521994A (ko) |
PT (1) | PT1267838E (ko) |
WO (1) | WO2001076558A1 (ko) |
ZA (1) | ZA200208039B (ko) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601685B2 (en) | 1998-08-27 | 2009-10-13 | Eidgenossische Technische Hochschule Zurich | Growth factor modified protein matrices for tissue engineering |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US20030003074A1 (en) * | 2001-06-14 | 2003-01-02 | Macromed, Inc. | Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR602401A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release delivery system |
EP1273314A1 (en) * | 2001-07-06 | 2003-01-08 | Terumo Kabushiki Kaisha | Stent |
WO2003017972A2 (en) * | 2001-08-27 | 2003-03-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers) |
CA2452194A1 (en) * | 2001-09-11 | 2003-03-20 | Smart Drug Systems Inc | Sustained release pharmaceutical compositions comprising a silicone support material |
EP1864681A1 (en) | 2001-12-18 | 2007-12-12 | Eidgenössische Technische Hochschule Zürich | Growth factor modified protein matrices for tissue engineering |
US7247609B2 (en) | 2001-12-18 | 2007-07-24 | Universitat Zurich | Growth factor modified protein matrices for tissue engineering |
US7635463B2 (en) | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
WO2003072143A1 (en) * | 2002-02-27 | 2003-09-04 | Pharmain, Ltd. | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
US20040076582A1 (en) * | 2002-08-30 | 2004-04-22 | Dimatteo Kristian | Agent delivery particle |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US7812120B2 (en) * | 2003-03-21 | 2010-10-12 | Par Pharmaceutical, Inc. | Nasal calcitonin formulations containing chlorobutanol |
EP1620072B1 (en) * | 2003-05-01 | 2008-03-26 | LTT Bio-Pharma Co., Ltd. | Zinc-containing sustained-release composition, its preparation, and method for producing the same |
KR20060129394A (ko) * | 2004-02-26 | 2006-12-15 | 독립행정법인 과학기술진흥기구 | 단백성 약물의 주사용 서방성 미립자 제제 및 이의제조방법 |
US7736671B2 (en) * | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
WO2005112977A2 (en) * | 2004-04-23 | 2005-12-01 | Pharmain, Ltd. | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
WO2006023849A2 (en) | 2004-08-20 | 2006-03-02 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
JP4990142B2 (ja) | 2004-08-23 | 2012-08-01 | マンカインド コーポレイション | 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩 |
JP2006111585A (ja) * | 2004-10-15 | 2006-04-27 | Mebiol Kk | 徐放性組成物およびその徐放方法 |
US20060252831A1 (en) * | 2005-05-06 | 2006-11-09 | Christopher Offen | Method for the treatment of magnesium and potassium deficiencies |
US20060252830A1 (en) * | 2005-05-06 | 2006-11-09 | Brandon Stephen F | Method for the treatment of magnesium and potassium deficiencies |
US20070015689A1 (en) * | 2005-06-23 | 2007-01-18 | Alza Corporation | Complexation of metal ions with polypeptides |
KR100810736B1 (ko) * | 2006-08-21 | 2008-03-07 | 광주과학기술원 | 다당류-기능화 나노입자 및 수화젤 담체를 포함하는복합체, 이를 포함하는 서방형 약물전달 제제, 뼈충진제 및이들의 제조방법 |
IN2014DN09128A (ko) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
WO2007059000A2 (en) * | 2005-11-10 | 2007-05-24 | Roskamp Research, Llc | Modulation of angiogenesis by a-beta peptide fragments |
EP3449946A3 (en) | 2005-12-19 | 2020-11-04 | PharmaIN Corporation | Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
US7501179B2 (en) * | 2005-12-21 | 2009-03-10 | Boston Scientific Scimed, Inc. | Block copolymer particles |
US20070142560A1 (en) * | 2005-12-21 | 2007-06-21 | Young-Ho Song | Block copolymer particles |
US7947368B2 (en) * | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
JP2010500340A (ja) * | 2006-08-11 | 2010-01-07 | パナセア バイオテック リミテッド | 活性成分を送達するための粒子、その製造方法、および組成物 |
US20080241256A1 (en) * | 2007-03-30 | 2008-10-02 | Liisa Kuhn | Targeted active agent delivery system based on calcium phosphate nanoparticles |
US7960336B2 (en) * | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
JP2012512812A (ja) | 2007-12-28 | 2012-06-07 | クロス・バイオサージェリー・アクチェンゲゼルシャフト | フィブリンフォームに組込まれたpdgf融合タンパク質 |
US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
RU2469726C2 (ru) | 2008-05-14 | 2012-12-20 | Отономи, Инк. | Композиции с контролируемым высвобождением на основе кортикостероидов для лечения ушных болезней |
ES2569556T3 (es) | 2008-06-03 | 2016-05-11 | Indivior Uk Limited | Complejo de inclusión de hidrogel deshidratado de un agente bioactivo con sistema fluido de administración de medicamento |
KR100951554B1 (ko) | 2008-06-04 | 2010-04-09 | 아주대학교산학협력단 | 마이셀 형성 및 약물 방출 제어가 가능한 6-팔plla-peg 블록 공중합체 |
EP3281663B8 (en) | 2008-06-13 | 2022-09-21 | MannKind Corporation | Breath powered dry powder inhaler for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
KR101367479B1 (ko) * | 2008-07-21 | 2014-03-14 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법 |
US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
CN102112111A (zh) * | 2008-12-22 | 2011-06-29 | 奥德纳米有限公司 | 用于治疗耳部病症的控制释放耳感觉细胞调节剂组合物和方法 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9636255B2 (en) | 2009-02-13 | 2017-05-02 | Dose Medical Corporation | Uveoscleral drug delivery implant and methods for implanting the same |
EP2429503A1 (en) * | 2009-05-13 | 2012-03-21 | Protein Delivery Solutions, LLC | Pharmaceutical system for trans-membrane delivery |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
WO2012071476A2 (en) | 2010-11-24 | 2012-05-31 | David Haffner | Drug eluting ocular implant |
US9718860B2 (en) * | 2009-11-03 | 2017-08-01 | Korea University Research And Business Foundation | Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof |
AU2011271097B2 (en) | 2010-06-21 | 2014-11-27 | Mannkind Corporation | Dry powder drug delivery system and methods |
ES2882852T3 (es) | 2011-03-16 | 2021-12-02 | Kuros Biosurgery Ag | Formulación farmacéutica para la utilización en la fusión espinal |
EP2694402B1 (en) | 2011-04-01 | 2017-03-22 | MannKind Corporation | Blister package for pharmaceutical cartridges |
CA2833023C (en) | 2011-04-11 | 2020-07-21 | Induce Biologics Inc. | System and method for multiphasic release of growth factors |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
CA2852536A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
WO2014012069A2 (en) | 2012-07-12 | 2014-01-16 | Mannkind Corporation | Dry powder drug delivery systems and methods |
US9062151B1 (en) | 2012-09-21 | 2015-06-23 | The United States of America, as represented by The Secretary of Agiculture | Protein-cyanoacrylate nanoparticles that improve wetting property of materials |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
AU2013388034B2 (en) | 2013-04-30 | 2019-08-15 | Vectura Inc. | Dry powder formulations and methods of use |
KR101496153B1 (ko) * | 2013-05-16 | 2015-02-27 | 오스템임플란트 주식회사 | 약물 담지 골형성 이식재 및 골 형성방법 |
CN105705173A (zh) * | 2013-05-24 | 2016-06-22 | 东北大学 | 用于将软组织整合入硬组织的纳米材料 |
CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
CN105682742A (zh) | 2013-08-27 | 2016-06-15 | 奥德纳米有限公司 | 小儿耳部病症的治疗 |
EP4119131A1 (en) | 2014-02-20 | 2023-01-18 | Otitopic Inc. | Dry powder formulations for inhalation |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US9895354B2 (en) | 2014-04-04 | 2018-02-20 | University Of Kentucky Research Foundation | Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
US10722468B2 (en) * | 2014-08-14 | 2020-07-28 | Brown University | Compositions for stabilizing and delivering proteins |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11564833B2 (en) | 2015-09-25 | 2023-01-31 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
CN109937025B (zh) | 2016-04-20 | 2022-07-29 | 多斯医学公司 | 生物可吸收眼部药物的递送装置 |
US11040004B2 (en) | 2016-09-16 | 2021-06-22 | Otonomy, Inc. | Otic gel formulations for treating otitis externa |
KR102001289B1 (ko) | 2016-10-13 | 2019-07-17 | 고려대학교 산학협력단 | 산화아연 결합 펩티드 서열, 이를 포함하는 복합체, 및 상기 복합체를 포함하는 약학 조성물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4765980A (en) * | 1986-04-28 | 1988-08-23 | International Minerals & Chemical Corp. | Stabilized porcine growth hormone |
US5538739A (en) | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
US5912015A (en) | 1992-03-12 | 1999-06-15 | Alkermes Controlled Therapeutics, Inc. | Modulated release from biocompatible polymers |
US5711968A (en) * | 1994-07-25 | 1998-01-27 | Alkermes Controlled Therapeutics, Inc. | Composition and method for the controlled release of metal cation-stabilized interferon |
EP0674506B1 (en) * | 1992-12-02 | 2000-08-23 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
KR100356550B1 (ko) * | 1994-09-09 | 2002-12-18 | 다케다 야쿠힌 고교 가부시키가이샤 | 펩티드의금속염을함유한서방성제제 |
BR9608542A (pt) * | 1995-06-07 | 1999-11-30 | Alkermes Inc | Composição para a liberação sustentada de hormónio do crescimento humano |
WO1998027962A2 (en) * | 1996-12-20 | 1998-07-02 | Alza Corporation | Injectable depot gel composition and method of preparing the composition |
US6113947A (en) * | 1997-06-13 | 2000-09-05 | Genentech, Inc. | Controlled release microencapsulated NGF formulation |
US6201072B1 (en) * | 1997-10-03 | 2001-03-13 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
CN1195788C (zh) * | 1997-10-03 | 2005-04-06 | 麦克罗梅德公司 | 具有可逆热胶凝性质的可生物降解低分子量三嵌段聚(丙交酯-共聚-乙交酯)聚乙二醇共聚物 |
US6287588B1 (en) * | 1999-04-29 | 2001-09-11 | Macromed, Inc. | Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
US6711968B2 (en) | 2002-08-02 | 2004-03-30 | Visteon Global Technologies, Inc. | Axle differential assembly |
-
2001
- 2001-04-05 US US09/827,100 patent/US6998137B2/en not_active Expired - Lifetime
- 2001-04-06 WO PCT/US2001/011217 patent/WO2001076558A1/en active IP Right Grant
- 2001-04-06 KR KR1020027013405A patent/KR100923817B1/ko not_active IP Right Cessation
- 2001-04-06 MX MXPA02009790A patent/MXPA02009790A/es active IP Right Grant
- 2001-04-06 DK DK01924765.9T patent/DK1267838T3/da active
- 2001-04-06 AT AT01924765T patent/ATE526947T1/de active
- 2001-04-06 AU AU2001251389A patent/AU2001251389A1/en not_active Abandoned
- 2001-04-06 JP JP2001574076A patent/JP4731088B2/ja not_active Expired - Fee Related
- 2001-04-06 ES ES01924765T patent/ES2374224T3/es not_active Expired - Lifetime
- 2001-04-06 PT PT01924765T patent/PT1267838E/pt unknown
- 2001-04-06 NZ NZ521994A patent/NZ521994A/en not_active IP Right Cessation
- 2001-04-06 EP EP01924765A patent/EP1267838B1/en not_active Expired - Lifetime
- 2001-04-06 CN CNB018099823A patent/CN100518814C/zh not_active Expired - Fee Related
- 2001-04-06 CA CA2405030A patent/CA2405030C/en not_active Expired - Fee Related
- 2001-04-06 IL IL15213101A patent/IL152131A0/xx unknown
- 2001-04-06 BR BRPI0110319A patent/BRPI0110319B1/pt not_active IP Right Cessation
-
2002
- 2002-10-06 IL IL152131A patent/IL152131A/en not_active IP Right Cessation
- 2002-10-07 ZA ZA200208039A patent/ZA200208039B/en unknown
-
2004
- 2004-01-19 HK HK04100051.2A patent/HK1057705A1/xx not_active IP Right Cessation
-
2010
- 2010-10-01 JP JP2010223933A patent/JP5193262B2/ja not_active Expired - Lifetime
-
2011
- 2011-12-22 CY CY20111101281T patent/CY1112294T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200208039B (en) | 2004-02-04 |
JP2004507450A (ja) | 2004-03-11 |
PT1267838E (pt) | 2012-01-11 |
ATE526947T1 (de) | 2011-10-15 |
WO2001076558A1 (en) | 2001-10-18 |
BRPI0110319B1 (pt) | 2016-09-27 |
DK1267838T3 (da) | 2012-01-23 |
MXPA02009790A (es) | 2003-06-19 |
KR20030009425A (ko) | 2003-01-29 |
US6998137B2 (en) | 2006-02-14 |
EP1267838B1 (en) | 2011-10-05 |
EP1267838A4 (en) | 2009-01-14 |
KR100923817B1 (ko) | 2009-10-27 |
JP2011026336A (ja) | 2011-02-10 |
IL152131A0 (en) | 2003-05-29 |
CN100518814C (zh) | 2009-07-29 |
BR0110319A (pt) | 2003-07-29 |
JP5193262B2 (ja) | 2013-05-08 |
US20020015737A1 (en) | 2002-02-07 |
ES2374224T3 (es) | 2012-02-14 |
AU2001251389A1 (en) | 2001-10-23 |
EP1267838A1 (en) | 2003-01-02 |
NZ521994A (en) | 2003-08-29 |
CA2405030C (en) | 2011-01-25 |
CN1430504A (zh) | 2003-07-16 |
CA2405030A1 (en) | 2001-10-18 |
CY1112294T1 (el) | 2015-12-09 |
JP4731088B2 (ja) | 2011-07-20 |
IL152131A (en) | 2010-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1057705A1 (en) | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix | |
WO1997026864A3 (en) | Methods and compositions for enhancing the bioadhesive properties of polymers | |
AUPQ573300A0 (en) | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use | |
UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
HUP0100237A2 (hu) | Térhálósított részecskék | |
BR9808933A (pt) | Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo | |
HRP20010463B1 (en) | Controlled release galantamine composition | |
ATE153535T1 (de) | Tgf-beta zusammensetzung zum herbeiführen von knochenwachstum | |
AU2002350592A1 (en) | Ph-sensitive polymer | |
CA2032499A1 (en) | Polypeptide derivatives | |
JP2002535108A5 (ko) | ||
AU3847997A (en) | Inhibitors of the interaction between P53 and MDM2 | |
WO2003079972A3 (en) | Active agent delivery systems and methods for protecting and administering active agents | |
EP1300139A3 (de) | Arzneistoffträgerpartikel für die gewebspezifische Arzneistoffapplikation | |
NO974404D0 (no) | Insufflasjonsbærer for medikamenter med kontrollert frigivelse | |
WO1997046585A3 (en) | Fragments of leptin (ob protein) | |
BRPI0409706A (pt) | composição compreendendo um polìmero catiÈnico intensificador de deposição em superfìcies | |
BR9908088A (pt) | Formulação farmacêutica de um composto de didemnin | |
CA2396223A1 (en) | Instant granules and process for their formulation | |
WO2001097785A3 (en) | Basic copolymers for the treatment of prion-related-disease | |
MY128312A (en) | Pesticidal formulation | |
AUPO089396A0 (en) | Neuroactive peptide | |
AU3499200A (en) | Deodorant compositions | |
NO20006572L (no) | Medikamenter inneholdende bisfosfonsyrer og deres derivater for forhindring og behandling av autoimmune sykdommer og allergier | |
HU9900251D0 (en) | Pharmaceutical compositions containing hedgehog proteins and use of former compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190409 |